Danaher Corporation acquired Nobel Biocare Holding AG for approximately CHF 1.9 billion (~$1.9 billion), CHF 17.10 per share cash tender, a transaction completed in December 2014, structured as all cash (tender offer).
Nobel Biocare Holding AG operates in Dental, is based in Zurich, Switzerland, had revenue of about EUR 567 million in 2013 (approximately $780 million). Danaher completed a tender offer for Nobel Biocare Holding AG in December 2014, acquiring 97% of outstanding shares; Nobel Biocare is a leader in high-precision individualized dental prosthetics, biomaterials and digital treatment planning.
Enhanced Danaher's dental business, adding implant-based dental restoration systems.
On December 11, 2014, the Company successfully completed its tender offer for the outstanding shares of common stock of Nobel Biocare Holding AG, acquiring 97% of the outstanding shares for an aggregate cash purchase price of approximately CHF 1.9 billion (approximately $1.9 billion based on exchange rates as of the date the shares of common stock were acquired) including debt assumed.Danaher Corporation FY14 10-K, acquisition note
Advisory firms were not disclosed for this transaction.